2021
DOI: 10.1111/imj.15450
|View full text |Cite
|
Sign up to set email alerts
|

Complete metabolic response following anaplastic lymphoma kinase (ALK) targeted therapy in a patient with adenocarcinoma of unknown primary with immunohistochemistry/fluorescence in situ hybridisation discordant ALK test results

Abstract: Complete metabolic response following anaplastic lymphoma kinase (ALK) targeted therapy in a patient with adenocarcinoma of unknown primary with immunohistochemistry/ fluorescence in situ hybridisation discordant ALK test resultsWe describe the case of a young man with anaplastic lymphoma kinase (ALK)-rearranged metastatic adenocarcinoma of unknown primary (aCUP) who, after presenting with disseminated intravascular coagulation (DIC), had a

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 6 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?